1 completed, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow HTLV-I-Associated Myelopathy: new trials by email Literature Review of HTLV-I-Associated Myelopathy trials Research Report on HTLV-I-Associated Myelopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Tamibarotene - HTLV-I-Associated Myelopathy | Phase 2 / Phase 3 | Terminated | St. Marianna University School of Medicine | 15 | 2011-01-01 | 2026-10-08 |
| Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial Zidovudine/lamivudine, Placebos - HTLV-I-associated Myelopathy | Phase 2 / Phase 3 | Completed | Imperial College London | 16 | 1999-11-08 | 2021-08-25 |
Paraparesis, Tropical Spastic (2)
Central Nervous System Diseases (2) · Central Nervous System Infections (2) · Deltaretrovirus Infections (2) · HTLV-I Infections (2) · Infections (2) · Myelitis (2) · Nervous System Diseases (2) · Neuroinflammatory Diseases (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Spinal Cord Diseases (2) · Virus Diseases (2)
lamivudine, zidovudine drug combination (1) · tamibarotene (1)
Imperial College London (1) · St. Marianna University School of Medicine (1)
Japan (1) · United Kingdom (1)
Graham P Taylor, FRCP (1) · Yoshihisa Yamano, MD (1)